Immunotherapy of CT26 Murine Tumors Is Characterized by an Oligoclonal Response of Tissue-Resident Memory T Cells Against the AH1 Rejection Antigen
Stringhini et al.
European Journal of Immunology
May 2020
Authors and Affiliates
Marco Stringhini 1, Philipp Probst 1, Dario Neri 1;
1Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zürich, Switzerland.
